Predict your next investment

Dokumeds company logo
BUSINESS PRODUCTS & SERVICES | Consulting & Outsourcing / Market, Industry & Competitive Research

See what CB Insights has to offer

Founded Year



Acquired | Alive

About Dokumeds

Dokumeds is a full-scope contract research organization (CRO) in Europe and South Africa. It helps pharma & biotech companies to accelerate clinical trials through faster enrollment. Its FSP capabilities include study start-up services, medical monitoring, medical writing, site audits, and more. It is based in Riga, Latvia.On December 8th, 2021, Dokumeds was acquired by Rho. The terms of the transaction were not disclosed.

Dokumeds Headquarter Location

Katrīnas dambis 20



Latest Dokumeds News

Rho Acquires European CRO Dokumeds

Dec 8, 2021

Rho Acquires European CRO Dokumeds Expands global reach and capabilities with complementary specialties and multinational footprint in Europe and beyond. 12.08.21 Rho , a full-service contract research organization ( CRO ), has acquired Dokumeds , a privately-held European CRO headquartered in Riga, Latvia, Dokumeds, with 10 offices and is active across multiple continents. Financial terms were not disclosed. “Our two companies are a great match, known for long-lasting relationships, scientific excellence and high-quality clinical development services,” said Laura Helms Reece, DrPH, CEO, Rho. “I’m thrilled to expand on our existing partnership and welcome Dokumeds to our company. Our teams are already aligned, ready to drive sponsors’ multinational programs forward to achieve development milestones and bring new and better treatments to patients. With this acquisition, Rho continues to offer focused therapeutic expertise as well as the attentiveness and agility of a medium-sized CRO, now with expanded global reach.”   “Dokumeds is delighted to join Rho, a fast-growing company that shares our passion for bringing new and improved therapies to the patients who need them,” said Indra Aboltina, MD, PhD, CEO, Dokumeds. “Our two companies already share a similar business culture and have complementary specialties and geographic footprints. This means that we are well on the way towards swift, smooth integration into a productive new entity that will help sponsors reach milestones more quickly and efficiently – globally.”   The combined companies will continue to provide full service clinical development services, from investigational new drug applications to regulatory submissions. Rho and Dokumeds’ organizational fit, operations, and manageable size will enable an accelerated integration process without delays or interruptions to client programs. Clients will benefit from expanded access to patients worldwide, with quality across countries and sites. 12.08.21 12.07.21 12.07.21 12.07.21 12.07.21 12.06.21 12.02.21 12.02.21 12.01.21 11.30.21 11.30.21 11.30.21 11.22.21 11.22.21 11.19.21

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.